Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Delayed Quote USD

Oncternal Therapeutics, Inc. (ONCT)

0.5266
-0.1674
(-24.12%)
At close: December 2 at 4:00:00 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
35,959
41,714
44,947
31,366
17,542
Operating Income
-35,959
-41,714
-44,947
-31,366
-17,542
Net Non Operating Interest Income Expense
1,384
2,235
777
33
16
Other Income Expense
--
--
--
--
301
Pretax Income
-34,575
-39,479
-44,170
-31,333
-17,225
Net Income Common Stockholders
-34,575
-39,479
-44,170
-31,333
-17,225
Diluted NI Available to Com Stockholders
-34,575
-39,479
-44,170
-31,333
-17,225
Basic EPS
-11.69
-13.43
-16.80
-12.80
-17.00
Diluted EPS
-11.69
-13.43
-16.80
-12.80
-17.00
Basic Average Shares
2,957.2500
2,940
2,629.7000
2,466.0500
1,015.2500
Diluted Average Shares
2,957.2500
2,940
2,629.7000
2,466.0500
1,015.2500
Total Operating Income as Reported
-35,959
-41,714
-44,947
-31,366
-17,542
Total Expenses
35,959
41,714
44,947
31,366
17,542
Net Income from Continuing & Discontinued Operation
-34,575
-39,479
-44,170
-31,333
-17,225
Normalized Income
-34,575
-39,479
-44,170
-31,333
-17,225
Interest Income
1,384
2,235
777
33
16
Net Interest Income
1,384
2,235
777
33
16
EBIT
-35,959
-41,714
-44,947
-31,366
-17,542
EBITDA
-35,959
-41,714
-44,947
-31,366
-17,542
Net Income from Continuing Operation Net Minority Interest
-34,575
-39,479
-44,170
-31,333
-17,225
Normalized EBITDA
-35,959
-41,714
-44,947
-31,366
-17,542
12/31/2020 - 2/3/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

27F0.F KALA BIO, Inc.
2.6120
-7.64%
 
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%
 
THAR Tharimmune, Inc.
1.2052
+3.90%
 
AFMD Affimed N.V.
0.7703
+4.24%
 
IKNA Ikena Oncology, Inc.
1.2100
+1.68%
 
STTK Shattuck Labs, Inc.
0.8513
-4.68%
 
PBLA Panbela Therapeutics, Inc.
0.3430
0.00%
 
TRDA Entrada Therapeutics, Inc.
8.71
0.00%
 
GYRE Gyre Therapeutics, Inc.
9.19
+6.37%
 
ELDN Eledon Pharmaceuticals, Inc.
3.3600
-0.59%